MAPT and Alzheimer disease: Compound P021, a neurotrophic peptidergic compound, that prevents deficiencies associated with neuronal plasticity and neurogenesis, was found to counteract Aβ plaque formation, reverse cognitive impairment, oppose tau pathologies, and intensely reduce the mortality rate in transgenic mice 3xTg‐AD.186, 187